BACKGROUND: Vitamin D and iron deficiencies frequently co-exist. It is now appreciated that mechanistic interactions between iron and vitamin D metabolism may underlie these associations. OBJECTIVE: We examined interrelations between iron and vitamin D status and their regulatory hormones in pregnant adolescents, who are a group at risk of both suboptimal vitamin D and suboptimal iron status. DESIGN: The trial was a prospective longitudinal study of 158 pregnant adolescents (aged ≤18 y). Maternal circulating biomarkers of vitamin D and iron were determined at midgestation (∼25 wk) and delivery (∼40 wk). Linear regression was used to assess associations between vitamin D and iron status indicators. Bivariate and multivariate logistic regressions were used to generate the OR of anemia as a function of vitamin D status. A mediation analysis was performed to examine direct and indirect relations between vitamin D status, hemoglobin, and erythropoietin in maternal serum. RESULTS: Maternal 25-hydroxyvitamin D [25(OH)D] was positively associated with maternal hemoglobin at both midgestation and at delivery (P < 0.01 for both). After adjustment for age at enrollment and race, the odds of anemia at delivery was 8 times greater in adolescents with delivery 25(OH)D concentrations <50 nmol/L than in those with 25(OH)D concentrations ≥50 nmol/L (P <0.001). Maternal 25(OH)D was inversely associated with erythropoietin at both midgestation (P <0.05) and delivery (P <0.001). The significant relation observed between 25(OH)D and hemoglobin could be explained by a direct relation between 25(OH)D and hemoglobin and an indirect relation that was mediated by erythropoietin. CONCLUSIONS: In this group of pregnant adolescents, suboptimal vitamin D status was associated with increased risk of iron insufficiency and vice versa. These findings emphasize the need for screening for multiple nutrient deficiencies during pregnancy and greater attention to overlapping metabolic pathways when selecting prenatal supplementation regimens.
BACKGROUND:Vitamin D and iron deficiencies frequently co-exist. It is now appreciated that mechanistic interactions between iron and vitamin D metabolism may underlie these associations. OBJECTIVE: We examined interrelations between iron and vitamin D status and their regulatory hormones in pregnant adolescents, who are a group at risk of both suboptimal vitamin D and suboptimal iron status. DESIGN: The trial was a prospective longitudinal study of 158 pregnant adolescents (aged ≤18 y). Maternal circulating biomarkers of vitamin D and iron were determined at midgestation (∼25 wk) and delivery (∼40 wk). Linear regression was used to assess associations between vitamin D and iron status indicators. Bivariate and multivariate logistic regressions were used to generate the OR of anemia as a function of vitamin D status. A mediation analysis was performed to examine direct and indirect relations between vitamin D status, hemoglobin, and erythropoietin in maternal serum. RESULTS: Maternal 25-hydroxyvitamin D [25(OH)D] was positively associated with maternal hemoglobin at both midgestation and at delivery (P < 0.01 for both). After adjustment for age at enrollment and race, the odds of anemia at delivery was 8 times greater in adolescents with delivery 25(OH)D concentrations <50 nmol/L than in those with 25(OH)D concentrations ≥50 nmol/L (P <0.001). Maternal 25(OH)D was inversely associated with erythropoietin at both midgestation (P <0.05) and delivery (P <0.001). The significant relation observed between 25(OH)D and hemoglobin could be explained by a direct relation between 25(OH)D and hemoglobin and an indirect relation that was mediated by erythropoietin. CONCLUSIONS: In this group of pregnant adolescents, suboptimal vitamin D status was associated with increased risk of iron insufficiency and vice versa. These findings emphasize the need for screening for multiple nutrient deficiencies during pregnancy and greater attention to overlapping metabolic pathways when selecting prenatal supplementation regimens.
Authors: Erik A Imel; Munro Peacock; Amie K Gray; Leah R Padgett; Siu L Hui; Michael J Econs Journal: J Clin Endocrinol Metab Date: 2011-08-31 Impact factor: 5.958
Authors: Zuguo Mei; Mary E Cogswell; Anne C Looker; Christine M Pfeiffer; Sarah E Cusick; David A Lacher; Laurence M Grummer-Strawn Journal: Am J Clin Nutr Date: 2011-03-23 Impact factor: 7.045
Authors: Meredith A Atkinson; Michal L Melamed; Juhi Kumar; Cindy N Roy; Edgar R Miller; Susan L Furth; Jeffrey J Fadrowski Journal: J Pediatr Date: 2013-10-08 Impact factor: 4.406
Authors: V Panichi; S De Pietro; B Andreini; A M Bianchi; M Migliori; D Taccola; L Giovannini; C Tetta; R Palla Journal: Kidney Int Date: 1998-11 Impact factor: 10.612
Authors: Erica L Clinkenbeard; Emily G Farrow; Lelia J Summers; Taryn A Cass; Jessica L Roberts; Christine A Bayt; Tim Lahm; Marjorie Albrecht; Matthew R Allen; Munro Peacock; Kenneth E White Journal: J Bone Miner Res Date: 2014-02 Impact factor: 6.741
Authors: Kimberly O O'Brien; Shuang Li; Chang Cao; Tera Kent; Bridget V Young; Ruth Anne Queenan; Eva K Pressman; Elizabeth M Cooper Journal: J Clin Endocrinol Metab Date: 2014-01-28 Impact factor: 5.958
Authors: Chang Cao; Eva K Pressman; Elizabeth M Cooper; Ronnie Guillet; Mark Westerman; Kimberly O O'Brien Journal: Reproduction Date: 2014-06-19 Impact factor: 3.906
Authors: Ellen M Smith; Jessica A Alvarez; Malcolm D Kearns; Li Hao; John H Sloan; Robert J Konrad; Thomas R Ziegler; Susu M Zughaier; Vin Tangpricha Journal: Clin Nutr Date: 2016-06-27 Impact factor: 7.324
Authors: Susan J van Rensburg; Ronald van Toorn; Kelebogile E Moremi; Armand V Peeters; Adesola Oguniyi; Maritha J Kotze Journal: Metab Brain Dis Date: 2016-01-08 Impact factor: 3.584
Authors: Saidah Wright; Dominique Earland; Swati Sakhuja; Anna Junkins; Sarah Franklin; Luz Padilla; Maung Aung; Pauline E Jolly Journal: Int J Womens Health Date: 2017-06-08